Brand names
Denosumab brand names
19 brands in 1 markets
Denosumab is sold under 19 brand names in 1 markets in our register data, including Aukelso, Bildyos, Bilprevda, Bomyntra, Boncresa, Bosaya. The table shows the market, marketing authorisation holder, strengths and forms for each brand, with the register it comes from.
| Brand | Market | Marketing authorisation holder | Strengths and forms | Source |
|---|---|---|---|---|
| Aukelso | United States | Biocon Biologics | 120 mg/1.7 mLInjection | US FDA NDC directoryChecked 12 November 2026 |
| Bildyos | United States | Organon | 60 mg/1 mLInjection | US FDA NDC directoryChecked 12 November 2026 |
| Bilprevda | United States | Organon | 120 mg/1.7 mLInjection | US FDA NDC directoryChecked 12 November 2026 |
| Bomyntra | United States | Fresenius Kabi | 119 mg/1.7 mLInjection | US FDA NDC directoryChecked 12 November 2026 |
| Boncresa | United States | Amneal Pharmaceuticals | 60 mg/1 mLInjection | US FDA NDC directoryChecked 12 November 2026 |
| Bosaya | United States | Biocon Biologics | 60 mg/1 mLInjection | US FDA NDC directoryChecked 12 November 2026 |
| Conexxence | United States | Fresenius Kabi | 60 mg/1 mLInjection | US FDA NDC directoryChecked 12 November 2026 |
| Enoby | United States | Hikma Pharmaceuticals | 60 mg/1 mLInjection | US FDA NDC directoryChecked 12 November 2026 |
| Jubbonti | United States | Sandoz | 60 mg/1 mLInjection | US FDA NDC directoryChecked 12 November 2026 |
| Jubereq | United States | Accord BioPharma | 119 mg/1.7 mLInjection | US FDA NDC directoryChecked 12 November 2026 |
| Osenvelt | United States | Celltrion | 120 mg/1.7 mLInjection | US FDA NDC directoryChecked 12 November 2026 |
| Ospomyv | United States | Cordavis | 60 mg/1 mLInjection | US FDA NDC directoryChecked 12 November 2026 |
| Osvyrti | United States | Accord BioPharma | 60 mg/1 mLInjection | US FDA NDC directoryChecked 12 November 2026 |
| Oziltus | United States | Amneal Pharmaceuticals | 119 mg/1.7 mLInjection | US FDA NDC directoryChecked 12 November 2026 |
| Prolia | United States | Amgen | 60 mg/1 mLInjection | US FDA NDC directoryChecked 12 November 2026 |
| Stoboclo | United States | Celltrion | 60 mg/1 mLInjection | US FDA NDC directoryChecked 12 November 2026 |
| Wyost | United States | Sandoz | 120 mg/1.7 mLInjection | US FDA NDC directoryChecked 12 November 2026 |
| Xgeva | United States | Amgen | 120 mg/1.7 mLInjection | US FDA NDC directoryChecked 12 November 2026 |
| Xtrenbo | United States | Hikma Pharmaceuticals | 120 mg/1.7 mLInjection | US FDA NDC directoryChecked 12 November 2026 |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Denosumab for export supply
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.